Foundational Neuroscience
Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents,
including how partial and inverse agonist functionality may impact the efficacy of
psychopharmacologic trea
...
Foundational Neuroscience
Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents,
including how partial and inverse agonist functionality may impact the efficacy of
psychopharmacologic treatments.
An agonist action is caused by a drug that purposefully binds to the receptors. The
agonist action then produces a detailed response to the targeted chemical and receptors.
Alternatively, an antagonistic activity is caused by a drug that binds the receptors causing the
receptors to seize from producing a reply. This agent's agonist to antagonist spectrum of action is
that one simulates reactions while the other stops or slows down responses. Often an agonist will
emulate the activities of a neurotransmitter and produce similar reactions to natural receptors of
which they bid.
Furthermore, agonists have affinity and efficacy, which means that they have target
receptors they bid to and can change receptor functionality to produce the desired response (Berg
& Clarke, 2018). Alternatively, antagonists have an affinity but cannot make a response.
Therefore, an antagonist will reduce the receptor ability of an agonist, thus reduction of receptor
response. In cases where there is a full agonist, the essential functions of an antagonist can be
blocked. This is because a full agonist produces a maximum response, whereas a partial one
produces partial responses. In some cases, a full agonist can make maximum response w
[Show More]